Literature DB >> 8361355

The obligate intracellular bacterium Chlamydia trachomatis is auxotrophic for three of the four ribonucleoside triphosphates.

G Tipples1, G McClarty.   

Abstract

Using well-characterized mutant host cell lines, deficient in specific enzymes of energy and nucleotide metabolism, we addressed numerous questions regarding nucleotide metabolism in the obligate intracellular bacterium Chlamydia trachomatis. The results presented indicate that C. trachomatis: (i) does not absolutely depend on mitochondrial generated ATP for survival; (ii) does have a significant draw on host-cell NTP pools but does not have a detrimental effect on the ability of the host cell to maintain its energy charge; (iii) lacks the ability to synthesize purine and pyrimidine nucleotides de novo; (iv) is not capable of interconverting purine nucleotides; and (v) possesses the pyrimidine metabolic-pathway enzymes CTP synthetase and deoxycytidine nucleotide deaminase. In total our results indicate that C. trachomatis is auxotrophic for host-cell ATP, GTP and UTP. In contrast, CTP can be obtained from the host cell or it can be synthesized from UTP by the parasite.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8361355     DOI: 10.1111/j.1365-2958.1993.tb01655.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  27 in total

Review 1.  Genome sequencing and our understanding of chlamydiae.

Authors:  D D Rockey; J Lenart; R S Stephens
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Chlamydia pneumoniae activates epithelial cell proliferation via NF-kappaB and the glucocorticoid receptor.

Authors:  Mikael M Cornelsen Gencay; Michael Tamm; Allan Glanville; André P Perruchoud; Michael Roth
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

3.  Interaction of Chlamydia trachomatis serovar L2 with the host autophagic pathway.

Authors:  Hesham M Al-Younes; Volker Brinkmann; Thomas F Meyer
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

4.  Beyond Tryptophan Synthase: Identification of Genes That Contribute to Chlamydia trachomatis Survival during Gamma Interferon-Induced Persistence and Reactivation.

Authors:  Matthew K Muramatsu; Julie A Brothwell; Barry D Stein; Timothy E Putman; Daniel D Rockey; David E Nelson
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

5.  Seminal levels of IL-10, IL-12, and IL-17 in men with asymptomatic chlamydia infection.

Authors:  Hamid Hakimi; Mohammad Mehdi Akhondi; Mohammad Reza Sadeghi; Leila Chamani; Mohammad Kazemi Arababadi; Behzad Nasiri Ahmadabadi; Gholamhossein Hassanshahi; Mahmoud Sheikh Fathollahi
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

6.  Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms.

Authors:  Hector A Saka; J Will Thompson; Yi-Shan Chen; Yadunanda Kumar; Laura G Dubois; M Arthur Moseley; Raphael H Valdivia
Journal:  Mol Microbiol       Date:  2011-11-07       Impact factor: 3.501

7.  Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis.

Authors:  Whitney Greene; Yangming Xiao; Yanqing Huang; Grant McClarty; Guangming Zhong
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Electron tomography and cryo-SEM characterization reveals novel ultrastructural features of host-parasite interaction during Chlamydia abortus infection.

Authors:  M Wilkat; E Herdoiza; V Forsbach-Birk; P Walther; A Essig
Journal:  Histochem Cell Biol       Date:  2014-02-13       Impact factor: 4.304

Review 9.  Acquisition of nutrients by Chlamydiae: unique challenges of living in an intracellular compartment.

Authors:  Hector Alex Saka; Raphael H Valdivia
Journal:  Curr Opin Microbiol       Date:  2009-12-16       Impact factor: 7.934

10.  Induction of type III secretion by cell-free Chlamydia trachomatis elementary bodies.

Authors:  Wendy P Jamison; Ted Hackstadt
Journal:  Microb Pathog       Date:  2008-10-17       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.